Wildflower Brands : to launch MiCovid Cam Temperature Scanners in all City Cannabis Retail Locations

VANCOUVER, British Columbia –TheNewswire –September 29, 2020:

Wildflower BrandsInc. (CSE:SUN) (OTC:WLDFF)(CNSX:SUN.CN)(the “Company”) announces that it will beusing the Direct Communication Solutions (CSE: DCSI , OTC: DCSX Intelligent Monitoring Solution MiCovid Cams in all City Cannabis locations. The launch is just one more precautionary measure being taken in our stores to ensure the safety and wellbeing of all patrons and staff that come to enjoy the unique shopping experience and premium products that City Cannabis has become synonymous with.

MiCovidCam is an Intelligent Monitoring solution featuring an AI thermal detector with cutting edge facial recognition and body temperature detection. Utilizing the latest AI chipset technology, MiCovid Cam offers immediate body temperature detection, the longest sensor range and the highest level of accuracy available in the market today. MiCovid Cam is fully integrated into the DCS Web Services API suite allowing third party and independent software developers to adopt body temperature data into their current and future software solutions. It is fast, non contact, non invasive and accurate so as to not delay or hamper the customer experience.

“MiCovid Cams will allow for a safe environment for our staff and ultimately bring in the customers that are still concerned about their health that might have not come to the store otherwise”, says Krystian Wetulani, President and CEO of City Cannabis. “This investment is for the safety of our loyal staff and customers and will ultimately bring in new consumers which will drive the bottom line”.

“With no end in sight of the COVID pandemic, there is no greater need to support businesses, schools, health care and public services with an Intelligent Monitoring solution capable of fast tracking the safe return of their employees, patrons, students and customers,” said Chris Bursey, CEO of DCS. “The MiCovid Cam supports stand-alone deployments of the system and is also supported by our Web Services API’s offering application developers in all markets, a seamless interface to adopt the MiCovid Cam data into their applications to support their customers.”

For more information on MiCovid Cam visit https://www.micovidcam.com/.


Wildflower Brands is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of our brands work in synergy, toward becoming a global wellness leader.

For more information about Wildflower Brands, visitwildflowerbrands.co. To learn, engage and shop our wellness products visitbuywildflower.com.


City Cannabis is a premier cannabis retailer recently acquired by Wildflower Brands and holds three City of Vancouver licenses to sell cannabis and four licenses in the Province of B.C. City Cannabis has been profitably operating various dispensaries in Vancouver since Vancouver commenced licensing cannabis retailers.

For more information about City Cannabis, visitcitycannabis.co.

Corporate Communications Contact:

Krystian Wetulani, Director & CDO

Doug Kerr

About DCS

DCS is a technology solutions integrator focusing on Intelligent Monitoring and connecting the Internet of Things (IoT). We provide real SaaS solutions that solve real business problems. Our software applications and scalable cloud services collect and assess business-critical data from all types of assets. DCS is headquartered in San Diego, California and is publicly traded on the OTC (“DCSX”) and Canadian Securities Exchange. For more information, visitwww.dcsbusiness.com.

DCS and the DCS logo are among the trademarks of DCS in the United States. Any other trademarks or trade names mentioned are the property of their respective owners.


Bill Espley, Director

Chris Bursey, CEO

Cautionary and Forward-Looking Statements

This news release contains forwardlooking statements and forwardlooking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forwardlooking statements or information. Forwardlooking statements and information are often, but not always, identified by the use of words such as “appear”, “seek”, “anticipate”, “plan”, “continue”, “estimate”, “approximate”, “expect”, “may”, “will”, “project”, “predict”, “potential”, “targeting”, “intend”, “could”, “might”, “should”, “believe”, “would” and similar expressions.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forwardlooking statements and information address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the risks associated with the cannabis industry in general such as operational risks in growing; competition; incorrect assessment of the value and potential benefits of various transactions; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and government regulations. Accordingly, readers should not place undue reliance on the forwardlooking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forwardlooking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forwardlooking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement The Canadian Securities Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release.

Like this article?

Share on facebook
Share on twitter
Share on linkedin